DCM
GILD icon

Dorato Capital Management’s Gilead Sciences GILD Stock Holding History

Dorato Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$73.4K Hold
565
– – 0.05% 157
2026
Q1 		$80K Hold
565
– – 0.06% 145
2025
Q4 		$70.1K Buy
+565
New +$68.7K 0.05% 152

Other funds holding GILD

Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Dorato Capital Management's GILD Position: Q2 2026 in Review

Dorato Capital Management held its Gilead Sciences (GILD) position steady in Q2 2026 at 565 shares worth $73.4K. The position accounts for 0.05% of the portfolio, ranked #157.

Dorato Capital Management first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. The position peaked at $80K in Q1 2026. 1,341 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Dorato Capital Management held 565 shares of Gilead Sciences worth $73.4K as of Q2 2026.
  • Dorato Capital Management left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.05% of Dorato Capital Management's portfolio in Q2 2026, its #157 holding.
  • Dorato Capital Management first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • Dorato Capital Management's Gilead Sciences position peaked at $80K in Q1 2026.
  • 1,341 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Dorato Capital Management's 13F filing for Q2 2026, filed 13 Jul 2026.